Materials Today Bio (Aug 2024)

Targeted therapy and deep learning insights into microglia modulation for spinal cord injury

  • Emilia Petillo,
  • Valeria Veneruso,
  • Gianluca Gragnaniello,
  • Lorenzo Brochier,
  • Enrico Frigerio,
  • Giuseppe Perale,
  • Filippo Rossi,
  • Andrea Cardia,
  • Alessandro Orro,
  • Pietro Veglianese

Journal volume & issue
Vol. 27
p. 101117

Abstract

Read online

Spinal cord injury (SCI) is a devastating condition that can cause significant motor and sensory impairment. Microglia, the central nervous system's immune sentinels, are known to be promising therapeutic targets in both SCI and neurodegenerative diseases. The most effective way to deliver medications and control microglial inflammation is through nanovectors; however, because of the variability in microglial morphology and the lack of standardized techniques, it is still difficult to precisely measure their activation in preclinical models. This problem is especially important in SCI, where the intricacy of the glia response following traumatic events necessitates the use of a sophisticated method to automatically discern between various microglial cell activation states that vary over time and space as the secondary injury progresses. We address this issue by proposing a deep learning-based technique for quantifying microglial activation following drug-loaded nanovector treatment in a preclinical SCI model. Our method uses a convolutional neural network to segment and classify microglia based on morphological characteristics. Our approach's accuracy and efficiency are demonstrated through evaluation on a collection of histology pictures from injured and intact spinal cords. This robust computational technique has potential for analyzing microglial activation across various neuropathologies and demonstrating the usefulness of nanovectors in modifying microglia in SCI and other neurological disorders. It has the ability to speed development in this crucial sector by providing a standardized and objective way to compare therapeutic options.